Search Results 101-110 of 16538 for Acrivastine
This condition affects the valve between the two right heart chambers. It can change the way blood flows through the heart. Learn about the different types.
Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility.
Mayo Clinic cardiologists, cardiovascular surgeons and others perform clinical research to develop new treatments and approaches to reduce the risk of heart ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...
Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...
The goal of this clinical trial is to learn if pacritinib works better than hydroxyurea to treat advanced proliferative chronic myelomonocytic leukemia in ...
The purpose of this study is to evaluate the safety and effectiveness of the BCL2 inhibitor BGB-11417 in participants with relapsed/refractory Waldenström's ...
The purpose of this study is to examine the safety and efficacy of Ibrutinib administered in combination with bendamustine and rituximab in patients with ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The goals of the study are to determine the safety and tolerability of X4P-001, as well as the potential effect it may have on the body and the cancer tumor.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.